Epidemiology Of Transition For Stage D Heart Failure

1529 Words7 Pages
Project: Epidemiology of Transition to Stage D Heart Failure, I was directly involved in data collection, data entry, result analysis and manuscript preparation. Our data result in four abstracts that had been accepted for presentation at AHA meeting 2015. Ongoing project. Clinical Trial: NEAT-HFpEF “ Nitrate’s Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction”. The purpose of this study is to evaluate whether isosorbide mononitrate (ISMN) compared to placebo increases daily activity as assessed by 14-day averaged arbitrary accelerometry units (AAU14). My contribution to this clinical trial was reviewing, comprehending the protocol, preparing IRB and other regulatory submission documents. I was involved in…show more content…
My contribution to this clinical trial was in preparing study materials, including informed consent document, case report forms, enrollment logs and drug/device accountability logs and I was involved in screening patients for the study. Project: “Pulmonary Function Testing and Prognosis in Heart Failure Patients Listed for Heart Transplantation”. The study examined the prediction power of spirometric variables on the prognosis among HF patients listed for heart transplantation. During this experience, I was actively involved in data collection, data entry and result analysis. I also had hands-on experience in the conduct and administration of the clinical research study protocol. The data were published in Cardiac Failure Journal August 2014 and had presented at the 18th Annual Scientific meeting of the Heart Failure Society of America, November 2014. Project: “Administrative” Versus Adjudicated Heart Failure with Preserved Ejection Fraction. I was directly involved in data collection, patient recruitment and manuscript preparation. I had the opportunity to work with investigators and research coordinators to learn about all aspects of clinical research, including human subjects, safety, data analysis, research ethics and regulatory requirements. Our abstract was published in Cardiac Failure Journal August 2014 and had presented at the 18th Annual Scientific meeting of the Heart Failure Society of America, November 2014. Project:
Open Document